Conversion of Psoriasis Patients from the Conventional Formulation of Cyclosporin A to a New Microemulsion Formulation: A Randomized, Open, Multicentre Assessment of Safety and Tolerability

Publisher： Karger

E-ISSN： 1421-9832|196|2|231-236

ISSN： 1018-8665

Source： Dermatology, Vol.196, Iss.2, 1998-03, pp. : 231-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

By  

Dermatology, Vol. 205, Iss. 4, 2002-12 ,pp. : 389-393

Karger

Access to resources Recommend Favorite

Effects of Cyclosporin A on Immune Activation Markers in Patients with Active Psoriasis

By  

Dermatology, Vol. 199, Iss. 2, 1999-10 ,pp. : 144-148

Karger

Access to resources Recommend Favorite

Dihydroxyacetone in a New Formulation – A Powerful Therapeutic Option in Vitiligo

By  

Dermatology, Vol. 203, Iss. 3, 2001-11 ,pp. : 241-243

Karger

Access to resources Recommend Favorite

Alefacept in the Treatment of Psoriasis in Patients for Whom Conventional Therapies Are Inadequate

By  

Dermatology, Vol. 211, Iss. 3, 2005-11 ,pp. : 256-263

Karger

Access to resources Recommend Favorite